Third Quarter Revenue Increased 19% Sequentially
vs. Second Quarter and Just Short of
Year Ago
New Product Transition Costs Temporarily Weighing
on Margins
Company Expecting Return to Year-over-Year
Revenue Growth in the Fourth Quarter
LEHI,
Utah, Nov. 9, 2023 /PRNewswire/ -- Purple
Innovation, Inc. (NASDAQ: PRPL) ("Purple"), a comfort innovation
company known for creating the "World's First No Pressure ™
Mattress," today announced results for the third quarter ended
September 30, 2023.
Third Quarter Financial Summary (Comparisons versus Third
Quarter 2022 and Second Quarter 2023)1
- Net revenue decreased 2.0% to $140.0
million compared to 3Q22 and increased 18.8% compared to
2Q23.
- Wholesale revenue increased 2.6% compared to 3Q22 and increased
20.0% compared to 2Q23.
- Direct-to-Consumer (DTC) revenue decreased 5.2% compared to
3Q22 and increased 17.8% compared to 2Q23.
- Gross margin was 33.8% compared to 41.3% in 3Q22 and 30.1% in
2Q23.
- Adjusted gross margin, which excludes discounts and
transitional costs associated with the new product transition, was
37.1% in 3Q23 compared to 37.2% in 2Q23.
- Operating expenses were $79.9
million, or 57.1% of revenue compared to $58.1 million, or 40.7% of revenue in 3Q22 and
$75.7 million, or 64.3% in 2Q23.
- Operating loss was $(32.6)
million compared to operating income of $0.9 million in 3Q22 and an operating loss of
($40.3) million in 2Q23.
- Net loss was $(36.0) million as
compared to net income of $2.0
million in 3Q22 and a net loss of $(40.5) million in 2Q23.
- Adjusted net loss was $(19.4)
million, or $(0.18) per
diluted share, as compared to adjusted net income of $2.5 million, or $0.03 per diluted share, in 3Q22 and adjusted net
loss of $(24.1) million, or
$(0.23) per diluted share, in
2Q23.
- EBITDA was $(29.7) million
compared to $7.0 million in 3Q22 and
$(34.3) million in 2Q23.
- Adjusted EBITDA decreased to $(16.3)
million compared to $11.8
million in 3Q22 and $(21.5)
million in 2Q23.
- Cash and cash equivalents were $26.6
million at September 30,
2023.
1
|
Reconciliations for
non-GAAP financial measures to the most directly comparable GAAP
financial measures are included in the "RECONCILIATION OF GAAP TO
NON-GAAP MEASURES" tables at the end of this press
release.
|
"Our third quarter top-line performance demonstrates that our
Path to Premium Sleep strategy is gaining traction," said Chief
Executive Officer Rob DeMartini. "Since launching our
innovative new mattresses and enhanced brand campaign in May and
converting the majority of our retail partner floor sets to our new
premium and luxury collections over the past several months, we've
seen a steady improvement in demand for Purple mattresses despite
ongoing industry softness. We are encouraged by the continued
sequential acceleration in revenue and we are focused on driving
further improvement across each of our distribution channels during
the fourth quarter and into 2024. While market conditions and
one-time costs associated with our new product transition have
pressured our bottom line this year, we remain confident that we
are well positioned to continue taking market share and deliver
sustained, profitable growth over the long-term."
Third Quarter 2023 Review
Third quarter 2023 net revenue decreased 2.0% to $140.0 million from $142.9
million in the third quarter of 2022. This decrease was
driven by soft demand for home related-products in the current
operating environment, nearly fully offset by the positive response
to the Company's new product lineup including its higher priced
Premium and Luxe collections, along with increased advertising
spend to support the new product launch and enhanced brand
positioning. By channel, wholesale revenue increased 2.6% and DTC
revenue declined 5.2%. DTC net revenues declined due to lower
e-commerce revenue partially offset by growth in Purple retail
showroom revenue driven by the addition of 5 showrooms over the
previous 12 months.
Gross margin for the third quarter 2023 decreased to 33.8%
compared to 41.3% in the year ago period. Adjusted gross margin,
which excludes discounts and one-time costs associated with the
product transition, was 37.1% in the current year quarter. These
discounts and costs include industry standard price reductions on
the sell-in of new mattress floor models to wholesale partners
coupled with increased discounting of discontinued models sold
through the Company's DTC channels associated with the transition
to the new premium and luxury product lineups. In addition, the
Company experienced increased labor and airfreight costs associated
with the new product launch. Net of these transitional items, gross
margins were impacted by the wrap-around on manufacturing
efficiencies from last year, when we had a higher amount of
inventory production, and a channel mix shift in revenue to
wholesale which carries a lower average selling price than DTC
channel sales. Wholesale revenues comprised approximately 43% of
net revenue for the quarter, compared with approximately 41% in the
same quarter last year.
Operating expenses were $79.9
million, or 57.1% of net revenue for the third quarter of
2023 compared to $58.1 million, or
40.7% of net revenue in the year ago period. This increase in
operating expenses was largely driven by a $12.6 million increase in advertising expenses to
support the new product launch including a new brand campaign that
highlights Purple's premium positioning and showcases the benefits
of its proprietary sleep technology and a $6.9 million loss on the impairment of
goodwill.
Operating loss was $(32.6) million
for the third quarter 2023 compared to operating income of
$0.9 million in the prior year
period.
Net loss attributable to Purple Innovation, Inc. was
$(36.0) million for the third quarter
2023 compared to net income of $2.0
million in the year ago period. Adjusted net income,
which excludes adjustments for certain non-cash items and other
items the Company does not consider in the evaluation of ongoing
operational performance, including losses associated with the
extinguishment of debt, impairment of goodwill, change in fair
value of warrant liabilities, Board special committee fees,
Acquisition expenses and gain on effective settlement in
acquisition was $(19.4) million, or
$(0.18) per diluted share, compared
to $2.5 million, or $0.03 per diluted share in the prior year period.
Adjusted net income has also been adjusted to reflect an estimated
effective income tax rate of 25.9% for the current year period and
25.1% for the comparable prior year period.
EBITDA for the third quarter 2023 was $(29.7) million compared to $7.0 million in the third quarter 2022. Adjusted
EBITDA was $(16.3) million compared
to Adjusted EBITDA of $11.8 million
in the prior year period.
Balance Sheet
As of September 30, 2023, the
Company had cash and cash equivalents of $26.6 million compared to $41.8 million as of December 31, 2022. The decrease was driven
primarily by cash used in operations of $55.8 million and capital expenditures of
$9.4 million primarily related to
additional manufacturing facility investments and showroom
expansion. This was partially offset by cash provided from net
proceeds of $57.0 million received
from the public offering completed in February 2023 and $25
million in proceeds from the new term loan put in place in
August. As of September 30,
2023, the Company had no amounts outstanding under its
credit facility. As we continue to pursue our growth strategies, we
will draw on our credit facility as needed and may also seek
additional funding sources to further fund growth and strengthen
liquidity, including new debt from subordinated lenders or equity
capital.
Inventories as of September 30,
2023, totaled $72.1 million
compared with $73.2 million as of
December 31, 2022, and $78.4 million as of June
30, 2023.
2023 Outlook
Based on results for the first nine-months of 2023 and a more
cautious view of industry demand for the remainder of the year, the
Company is adjusting its outlook. It now expects net revenue
to be in the range of $510 to
$520 million and negative adjusted
EBITDA between $(65) million and
$(55) million.
Conference Call and Webcast Information
Purple Innovation, Inc. will host a live conference call to
discuss financial results today, November 9,
2023 at 4:30 p.m. Eastern
Time. To access the call dial (888) 300-3045
(domestic) or (646) 568-1027 (international) and provide the
Conference ID: 8565527. The call is also being webcast and can be
accessed on the investor relations section of the Company's
website, investors.purple.com. After the conference call, a webcast
replay will remain available on the investor relations section of
the Company's website for 30 days.
About Purple
Purple, the leading premium mattress company with the #1 Gel
Grid technology in the world, the GelFlex® Grid,
thoughtfully engineers products that make restorative sleep
effortless for every kind of sleeper. The result of over 30 years
of innovation and in comfort technologies, Purple's GelFlex Grid is
the most significant advancement in mattresses in decades and is
proven to reduce aches and pains. It instantly adapts as you move,
balances temperature, relieves pressure and offers support in all
the right places. Purple products, including mattresses, pillows,
cushions, frames, sheets, and more, can be found online
at Purple.com, in 57 Purple stores and over 3,000 retailers
nationwide. Sleep Better. Live Purple.
Forward Looking Statements
Certain statements made in this release that are not historical
facts are "forward looking statements" within the meaning of the
"safe harbor" provisions of the United States Private Securities
Litigation Reform Act of 1995. Such forward-looking statements
include but are not limited to statements relating to our expected
continuing expansion of market share from investment in expanded
product lines, innovation and showrooms; our ability to achieve
profitability; expected improvements in performance
quarter-over-quarter and growth in the second half of the year;
expected improvement in margin rates; our ability to successfully
execute on improvement strategies, including right-sizing our cost
structure and improving supply chain and manufacturing efficiency,
and related impacts on our operating results; expected improvements
in our operating performance, including wholesale relationships;
demand for our products; expectations regarding consumer behavior;
the timing and impact of the introduction of new product lines; the
adequacy of our cash and other capital resources; and expected
financial and operating results for the fourth quarter or full year
2023, including net revenue and Adjusted EBITDA. Statements based
on historical data are not intended and should not be understood to
indicate the Company's expectations regarding future events.
Forward-looking statements provide current expectations or
forecasts of future events or determinations. These forward-looking
statements are not guarantees of future performance, conditions or
results, and involve a number of known and unknown risks,
uncertainties, assumptions and other important factors, many of
which are outside the Company's control, that could cause actual
results or outcomes to differ materially from those discussed in
the forward-looking statements. Factors that could influence the
realization of forward-looking statements include, among others:
changes in economic, financial and end-market conditions in the
markets in which we operate; fluctuations in raw material prices
and cost of labor; the financial condition of our customers and
suppliers; competitive pressures, including the need for technology
improvement, successful new product development and introduction;
changes in consumer demand, including pullbacks in consumer
spending; disruptions to our manufacturing processes; and the risk
factors outlined in the "Risk Factors" section of our Annual Report
on Form 10-K filed with the Securities and Exchange Commission (the
"SEC") on March 22, 2023 as amended
on Form 10-K/A filed with the SEC on May 1,
2023, and in our other filings made with the SEC. The
Company does not undertake any obligation to update or revise any
forward-looking statements, whether as a result of new information,
future events or otherwise, except as required by law.
Presentation
The financial results included in this earnings release reflect
adjustments to prior period warranty liability amounts.
Non-GAAP Financial Measures
EBITDA, adjusted EBITDA, adjusted gross margin, adjusted net
income, and adjusted net income per diluted share are non-GAAP
financial measures that remove the impact of certain non-cash and
non-
recurring costs. Management believes that the use of such
non-GAAP financial measures provides investors with additional
useful information with respect to the impact of various
adjustments, which we view as a better measure of our operating
performance. Refer to the attached table for the reconciliation of
such non-GAAP financial measures to the most comparable GAAP
financial measure.
With respect to the Company's Adjusted EBITDA outlook for the
fourth quarter and full year 2023, a quantitative reconciliation to
the corresponding GAAP information cannot be provided without
unreasonable effort because of the inherent difficulty of
accurately forecasting the occurrence and financial impact of the
various adjusting items necessary for such reconciliation that have
not yet occurred, are out of our control, or cannot be reasonably
predicted, including but not limited to warrant liabilities and
stock based compensation. For the same reasons, the Company is
unable to assess the probable significance of the unavailable
information, which could have a material impact on its future GAAP
financial results.
Investor Contact:
Brendon
Frey, ICR
brendon.frey@icrinc.com
203-682-8200
PURPLE INNOVATION,
INC.
Condensed
Consolidated Balance Sheets
(unaudited – in
thousands, except for par value)
|
|
|
|
|
|
September 30,
2023
|
|
|
December 31,
2022
|
|
Assets
|
|
|
|
|
|
|
Current
assets:
|
|
|
|
|
|
|
Cash, cash equivalents and restricted cash
|
|
$
|
26,606
|
|
|
$
|
41,754
|
|
Accounts receivable, net
|
|
|
32,686
|
|
|
|
34,566
|
|
Inventories, net
|
|
|
72,085
|
|
|
|
73,197
|
|
Prepaid expenses
|
|
|
8,807
|
|
|
|
7,821
|
|
Other current assets
|
|
|
1,989
|
|
|
|
4,117
|
|
Total current
assets
|
|
|
142,173
|
|
|
|
161,455
|
|
Property and equipment,
net
|
|
|
129,580
|
|
|
|
136,673
|
|
Operating lease
right-of-use assets
|
|
|
100,739
|
|
|
|
102,541
|
|
Goodwill
|
|
|
—
|
|
|
|
4,897
|
|
Intangible assets,
net
|
|
|
22,971
|
|
|
|
26,221
|
|
Other long-term
assets
|
|
|
2,510
|
|
|
|
1,546
|
|
Total assets
|
|
$
|
397,973
|
|
|
$
|
433,333
|
|
|
|
|
|
|
|
|
|
|
Liabilities and Stockholders'
Equity
|
|
|
|
|
|
|
|
|
Current
liabilities:
|
|
|
|
|
|
|
|
|
Accounts payable
|
|
$
|
45,720
|
|
|
$
|
46,441
|
|
Accrued sales returns
|
|
|
4,971
|
|
|
|
5,107
|
|
Accrued compensation
|
|
|
6,220
|
|
|
|
6,691
|
|
Customer prepayments
|
|
|
5,175
|
|
|
|
4,452
|
|
Accrued sales and use tax
|
|
|
1,876
|
|
|
|
2,978
|
|
Accrued rebates and allowances
|
|
|
8,575
|
|
|
|
9,804
|
|
Operating lease obligations – current portion
|
|
|
14,771
|
|
|
|
13,708
|
|
Other current liabilities
|
|
|
14,664
|
|
|
|
8,948
|
|
Total current
liabilities
|
|
|
101,972
|
|
|
|
98,129
|
|
Debt
|
|
|
22,483
|
|
|
|
23,657
|
|
Operating lease
obligations, net of current portion
|
|
|
114,196
|
|
|
|
115,599
|
|
Other long-term
liabilities, net of current portion
|
|
|
26,306
|
|
|
|
20,777
|
|
Total
liabilities
|
|
|
264,957
|
|
|
|
258,162
|
|
Commitments and
contingencies (Note 15)
|
|
|
|
|
|
|
|
|
Stockholders'
equity:
|
|
|
|
|
|
|
|
|
Class A common stock; $0.0001 par value, 210,000 shares authorized;
105,333
issued and outstanding at September 30, 2023 and 91,380 issued and
outstanding at December 31, 2022
|
|
|
11
|
|
|
|
9
|
|
Class B common stock; $0.0001 par value, 90,000 shares authorized;
418 issued
and outstanding at September 30, 2023 and 448 issued and
outstanding at December 31, 2022
|
|
|
—
|
|
|
|
—
|
|
Additional paid-in capital
|
|
|
590,096
|
|
|
|
529,466
|
|
Accumulated deficit
|
|
|
(457,636)
|
|
|
|
(355,212)
|
|
Total stockholders'
equity attributable to Purple Innovation, Inc.
|
|
|
132,471
|
|
|
|
174,263
|
|
Noncontrolling interest
|
|
|
545
|
|
|
|
908
|
|
Total stockholders'
equity
|
|
|
133,016
|
|
|
|
175,171
|
|
Total liabilities and
stockholders' equity
|
|
$
|
397,973
|
|
|
$
|
433,333
|
|
PURPLE INNOVATION,
INC.
Condensed
Consolidated Statements of Operations
(unaudited – in
thousands, except per share amounts)
|
|
|
|
|
|
Three Months Ended
September 30,
|
|
|
Nine Months Ended
September 30,
|
|
|
|
2023
|
|
|
2022
|
|
|
2023
|
|
|
2022
|
|
Revenues,
net
|
|
$
|
139,996
|
|
|
$
|
142,867
|
|
|
$
|
364,605
|
|
|
$
|
428,896
|
|
Cost of
revenues
|
|
|
92,687
|
|
|
|
83,867
|
|
|
|
241,244
|
|
|
|
270,717
|
|
Gross profit
|
|
|
47,309
|
|
|
|
59,000
|
|
|
|
123,361
|
|
|
|
158,179
|
|
Operating
expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Marketing and
sales
|
|
|
52,816
|
|
|
|
37,007
|
|
|
|
137,368
|
|
|
|
127,339
|
|
General and
administrative
|
|
|
17,524
|
|
|
|
19,166
|
|
|
|
67,628
|
|
|
|
55,833
|
|
Research and
development
|
|
|
2,704
|
|
|
|
1,927
|
|
|
|
9,001
|
|
|
|
5,818
|
|
Loss on impairment of
goodwill
|
|
|
6,879
|
|
|
|
—
|
|
|
|
6,879
|
|
|
|
—
|
|
Total operating
expenses
|
|
|
79,923
|
|
|
|
58,100
|
|
|
|
220,876
|
|
|
|
188,990
|
|
Operating income
(loss)
|
|
|
(32,614)
|
|
|
|
900
|
|
|
|
(97,515)
|
|
|
|
(30,811)
|
|
Other income
(expense):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest
expense
|
|
|
(594)
|
|
|
|
(717)
|
|
|
|
(1,148)
|
|
|
|
(2,447)
|
|
Other income,
net
|
|
|
205
|
|
|
|
1,107
|
|
|
|
315
|
|
|
|
988
|
|
Change in
fair value – warrant liabilities
|
|
|
—
|
|
|
|
(53)
|
|
|
|
—
|
|
|
|
4,221
|
|
Loss on extinguishment
of debt
|
|
|
(3,114)
|
|
|
|
—
|
|
|
|
(4,331)
|
|
|
|
—
|
|
Total other income
(expense), net
|
|
|
(3,503)
|
|
|
|
337
|
|
|
|
(5,164)
|
|
|
|
2,762
|
|
Net income (loss)
before income taxes
|
|
|
(36,117)
|
|
|
|
1,237
|
|
|
|
(102,679)
|
|
|
|
(28,049)
|
|
Income tax benefit
(expense)
|
|
|
(18)
|
|
|
|
720
|
|
|
|
(162)
|
|
|
|
7,036
|
|
Net income
(loss)
|
|
|
(36,135)
|
|
|
|
1,957
|
|
|
|
(102,841)
|
|
|
|
(21,013)
|
|
Net income (loss)
attributable to noncontrolling interest
|
|
|
(131)
|
|
|
|
1
|
|
|
|
(417)
|
|
|
|
(204)
|
|
Net income (loss)
attributable to Purple Innovation, Inc.
|
|
$
|
(36,004)
|
|
|
$
|
1,956
|
|
|
$
|
(102,424)
|
|
|
$
|
(20,809)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) per
share:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
$
|
(0.34)
|
|
|
$
|
0.02
|
|
|
$
|
(0.99)
|
|
|
$
|
(0.27)
|
|
Diluted
|
|
$
|
(0.34)
|
|
|
$
|
0.02
|
|
|
$
|
(0.99)
|
|
|
$
|
(0.27)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average common
shares outstanding:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
|
105,326
|
|
|
|
85,666
|
|
|
|
102,962
|
|
|
|
78,544
|
|
Diluted
|
|
|
105,326
|
|
|
|
86,115
|
|
|
|
102,962
|
|
|
|
78,992
|
|
PURPLE INNOVATION,
INC.
Condensed
Consolidated Statements of Cash Flows
(unaudited – in
thousands)
|
|
|
|
|
|
Three Months Ended September
30,
|
|
|
Nine Months Ended
September 30,
|
|
|
|
2023
|
|
|
2022
|
|
|
2023
|
|
|
2022
|
|
Cash flows from
operating activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
(loss)
|
|
$
|
(36,135)
|
|
|
$
|
1,957
|
|
|
$
|
(102,841)
|
|
|
$
|
(21,013)
|
|
Adjustments to
reconcile net income (loss) to net cash provided by
(used in) operating
activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation and
amortization
|
|
|
6,073
|
|
|
|
4,622
|
|
|
|
18,963
|
|
|
|
12,205
|
|
Non-cash
interest
|
|
|
234
|
|
|
|
523
|
|
|
|
920
|
|
|
|
883
|
|
Loss on extinguishment
of debt
|
|
|
3,114
|
|
|
|
—
|
|
|
|
4,331
|
|
|
|
—
|
|
Loss on impairment of
goodwill
|
|
|
6,879
|
|
|
|
—
|
|
|
|
6,879
|
|
|
|
—
|
|
Change in fair value -
warrant liabilities
|
|
|
—
|
|
|
|
53
|
|
|
|
—
|
|
|
|
(4,221)
|
|
Stock-based
compensation
|
|
|
939
|
|
|
|
795
|
|
|
|
3,792
|
|
|
|
2,612
|
|
Gain from effective
settlement of preexisting relationship
|
|
|
—
|
|
|
|
(1,421)
|
|
|
|
—
|
|
|
|
(1,421)
|
|
Deferred income
taxes
|
|
|
—
|
|
|
|
(689)
|
|
|
|
—
|
|
|
|
(6,850)
|
|
Changes in operating
assets and liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accounts
receivable
|
|
|
(10,002)
|
|
|
|
6,607
|
|
|
|
1,465
|
|
|
|
459
|
|
Inventories,
net
|
|
|
5,757
|
|
|
|
(2,325)
|
|
|
|
696
|
|
|
|
11,479
|
|
Prepaid inventory and
other assets
|
|
|
(4,156)
|
|
|
|
(3,589)
|
|
|
|
(1,204)
|
|
|
|
(108)
|
|
Operating lease,
net
|
|
|
147
|
|
|
|
2,227
|
|
|
|
1,462
|
|
|
|
6,405
|
|
Accounts
payable
|
|
|
(2,760)
|
|
|
|
10,412
|
|
|
|
544
|
|
|
|
(26,615)
|
|
Accrued sales
returns
|
|
|
774
|
|
|
|
189
|
|
|
|
(136)
|
|
|
|
(1,816)
|
|
Accrued
compensation
|
|
|
1,908
|
|
|
|
1,236
|
|
|
|
(801)
|
|
|
|
1,590
|
|
Customer
prepayments
|
|
|
(302)
|
|
|
|
(1,400)
|
|
|
|
723
|
|
|
|
(7,122)
|
|
Accrued rebates and
allowances
|
|
|
2,748
|
|
|
|
736
|
|
|
|
(1,229)
|
|
|
|
(2,118)
|
|
Other accrued
liabilities
|
|
|
7,027
|
|
|
|
2,397
|
|
|
|
10,628
|
|
|
|
5,177
|
|
Net cash provided by
(used in) operating activities
|
|
|
(17,755)
|
|
|
|
22,330
|
|
|
|
(55,808)
|
|
|
|
(30,474)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from
investing activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Excess restricted cash
returned to acquiree
|
|
|
(826)
|
|
|
|
—
|
|
|
|
(826)
|
|
|
|
—
|
|
Cash, cash equivalents
and restricted cash acquired from acquisition, net of cash
paid
|
|
|
—
|
|
|
|
3,648
|
|
|
|
—
|
|
|
|
3,648
|
|
Purchase of property
and equipment
|
|
|
(3,326)
|
|
|
|
(7,189)
|
|
|
|
(8,769)
|
|
|
|
(31,422)
|
|
Investment in
intangible assets
|
|
|
(208)
|
|
|
|
(815)
|
|
|
|
(588)
|
|
|
|
(2,637)
|
|
Net cash used in
investing activities
|
|
|
(4,360)
|
|
|
|
(4,356)
|
|
|
|
(10,183)
|
|
|
|
(30,411)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from
financing activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Payments on term
loan
|
|
|
—
|
|
|
|
—
|
|
|
|
(24,656)
|
|
|
|
(2,531)
|
|
Payments on revolving
line of credit
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
(55,000)
|
|
Proceeds from term
loan
|
|
|
25,000
|
|
|
|
—
|
|
|
|
25,000
|
|
|
|
—
|
|
Payments for debt
issuance costs
|
|
|
(3,228)
|
|
|
|
—
|
|
|
|
(6,126)
|
|
|
|
(1,242)
|
|
Proceeds from stock
offering
|
|
|
—
|
|
|
|
—
|
|
|
|
60,300
|
|
|
|
98,210
|
|
Payments for public
offering costs
|
|
|
—
|
|
|
|
—
|
|
|
|
(3,301)
|
|
|
|
(5,344)
|
|
Proportional
Representation Preferred Linked Stock redemption fee
|
|
|
—
|
|
|
|
—
|
|
|
|
(105)
|
|
|
|
—
|
|
Tax receivable
agreement payments
|
|
|
—
|
|
|
|
—
|
|
|
|
(269)
|
|
|
|
(5,847)
|
|
Proceeds from exercise
of stock options
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
166
|
|
Net cash provided by
(used in) financing activities
|
|
|
21,772
|
|
|
|
—
|
|
|
|
50,843
|
|
|
|
28,412
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net increase (decrease)
in cash
|
|
|
(343)
|
|
|
|
17,974
|
|
|
|
(15,148)
|
|
|
|
(32,473)
|
|
Cash, beginning of the
period
|
|
|
26,949
|
|
|
|
41,169
|
|
|
|
41,754
|
|
|
|
91,616
|
|
Cash, end of the
period
|
|
$
|
26,606
|
|
|
$
|
59,143
|
|
|
$
|
26,606
|
|
|
$
|
59,143
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PURPLE INNOVATION,
INC.
RECONCILIATION OF GAAP TO NON-GAAP
MEASURES
(In thousands)
Management believes that the use of the following non-GAAP
financial measures provides investors with additional useful
information with respect to the impact of various adjustments,
which we view as a better measure of our operating performance.
These non-GAAP financial measures are EBITDA, adjusted EBITDA,
adjusted net income, and adjusted net income per diluted share.
Other companies may calculate these non-GAAP measures differently
than we do. These non-GAAP measures have limitations as analytical
tools, and you should not consider them in isolation or as a
substitute for our financial results prepared in accordance with
GAAP.
Reconciliation of GAAP Net Income (Loss) to Non-GAAP EBITDA
and Adjusted EBITDA
A reconciliation of GAAP net income (loss) to the non-GAAP
measures of EBITDA and adjusted EBITDA is provided below. EBITDA
represents net income (loss) before interest expense, income tax
(benefit) expense, other (income) expense, net, and depreciation
and amortization. Adjusted EBITDA represents EBITDA excluding costs
incurred due to stock-based compensation expense, debt
extinguishment, changes in the fair value of the warrant liability,
impairment of goodwill, nonrecurring legal fees, Board special
committee costs, executive interim and search costs, severance
costs, vendor separation fee, showroom opening costs, new
production facility start-up costs and COVID-19 related expenses.
We believe EBITDA and Adjusted EBITDA provide additional useful
information with respect to the impact of various adjustments and
provide meaningful measures of our operating performance.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
September 30,
|
|
|
Nine Months Ended
September 30,
|
|
|
|
2023
|
|
|
2022
|
|
|
2023
|
|
|
2022
|
|
GAAP net income
(loss)
|
|
$
|
(36,135)
|
|
|
|
1,957
|
|
|
|
(102,841)
|
|
|
|
(21,013)
|
|
Interest
expense
|
|
|
594
|
|
|
|
717
|
|
|
|
1,148
|
|
|
|
2,447
|
|
Income tax (benefit)
expense
|
|
|
18
|
|
|
|
(631)
|
|
|
|
162
|
|
|
|
(6,617)
|
|
Other income,
net
|
|
|
(205)
|
|
|
|
314
|
|
|
|
(315)
|
|
|
|
433
|
|
Depreciation and
amortization
|
|
|
6,072
|
|
|
|
4,622
|
|
|
|
18,962
|
|
|
|
12,205
|
|
EBITDA
|
|
|
(29,656)
|
|
|
|
6,979
|
|
|
|
(82,884)
|
|
|
|
(12,545)
|
|
Adjustments:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in fair value -
warrant liability
|
|
|
—
|
|
|
|
53
|
|
|
|
—
|
|
|
|
(4,221)
|
|
Loss on extinguishment
of debt
|
|
|
3,114
|
|
|
|
—
|
|
|
|
4,331
|
|
|
|
—
|
|
Stock-based
compensation expense
|
|
|
939
|
|
|
|
795
|
|
|
|
3,792
|
|
|
|
2,612
|
|
Loss on impairment of
goodwill
|
|
|
6,879
|
|
|
|
—
|
|
|
|
6,879
|
|
|
|
—
|
|
Vendor separation
fee
|
|
|
—
|
|
|
|
—
|
|
|
|
1,050
|
|
|
|
3,136
|
|
Legal fees
|
|
|
775
|
|
|
|
227
|
|
|
|
3,520
|
|
|
|
493
|
|
Board special committee
fees
|
|
|
—
|
|
|
|
—
|
|
|
|
14,160
|
|
|
|
—
|
|
Acquisition
expenses
|
|
|
—
|
|
|
|
3,389
|
|
|
|
65
|
|
|
|
3,389
|
|
Gain on effective
settlement in acquisition
|
|
|
—
|
|
|
|
(1,421)
|
|
|
|
—
|
|
|
|
(1,421)
|
|
Executive interim and
search costs
|
|
|
1,456
|
|
|
|
1,014
|
|
|
|
3,258
|
|
|
|
4,084
|
|
Severance
costs
|
|
|
—
|
|
|
|
—
|
|
|
|
586
|
|
|
|
2,469
|
|
Showroom opening
costs
|
|
|
242
|
|
|
|
740
|
|
|
|
338
|
|
|
|
2,316
|
|
New production facility
start-up costs
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
348
|
|
COVID-19 related
expenses
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
331
|
|
Adjusted
EBITDA
|
|
$
|
(16,251)
|
|
|
|
11,776
|
|
|
|
(44,905)
|
|
|
|
991
|
|
|
|
|
|
(in
thousands)
|
|
Three Months Ended June 30,
2023
|
GAAP net income
(loss)
|
|
$
|
(40,654)
|
|
Interest
expense
|
|
|
352
|
|
Income tax (benefit)
expense
|
|
|
72
|
|
Other income,
net
|
|
|
(37)
|
|
Depreciation and
amortization
|
|
|
6,007
|
|
EBITDA
|
|
|
(34,260)
|
|
Adjustments:
|
|
|
|
|
Stock-based
compensation expense
|
|
|
1,661
|
|
Legal fees
|
|
|
1,395
|
|
Board special committee
fees
|
|
|
8,298
|
|
Acquisition
expenses
|
|
|
65
|
|
Executive interim and
search costs
|
|
|
1,013
|
|
Severance
costs
|
|
|
267
|
|
Showroom opening
costs
|
|
|
39
|
|
Adjusted
EBITDA
|
|
$
|
(21,522)
|
|
Reconciliation of GAAP Gross Margin to Adjusted Gross
Margin
A reconciliation of GAAP gross margin to the non-GAAP measure of
adjusted gross margin is provided below. Adjusted gross margin
represents adjusted net revenue less adjusted cost of
revenues. Adjusted revenue represents revenue adjusted for
revenue deemed lost through discounts on products during our
transition to our new product line. Adjusted cost of revenues
presents cost of revenues excluding certain incremental costs
incurred during our transition to our new product line. We believe
adjusted gross margin provides additional useful information with
respect to the impact of certain temporary or one-time items and
provides a meaningful measure of our operating performance.
(in
thousands except percentages)
|
|
Three Months Ended
|
|
|
|
September 30,
2023
|
|
|
June 30, 2023
|
|
Net revenue
|
|
$
|
139,996
|
|
|
$
|
117,882
|
|
Discounts on new
product transition
|
|
|
3,124
|
|
|
|
9,628
|
|
Adjusted net
revenue
|
|
|
143,120
|
|
|
|
127,510
|
|
|
|
|
|
|
|
|
|
|
Cost of
revenues
|
|
|
92,687
|
|
|
|
82,408
|
|
Costs of new product
transition
|
|
|
2,692
|
|
|
|
2,323
|
|
Adjusted cost of
revenues
|
|
|
89,995
|
|
|
|
80,085
|
|
|
|
|
|
|
|
|
|
|
Adjusted gross
margin
|
|
$
|
53,125
|
|
|
$
|
47,425
|
|
Adjusted gross margin
%
|
|
|
37.1 %
|
|
|
|
37.2 %
|
|
Reconciliation of GAAP Net Income to non-GAAP Adjusted Net
Income and Adjusted Net Income per Diluted Share
Our presentation of adjusted net income assumes that all net
income is attributable to Purple Innovation, Inc. (i.e. there is no
allocation of net income or loss to noncontrolling interests),
which assumes the full exchange at the beginning of the period of
all outstanding Paired Securities for shares of Class A common
stock of Purple Innovation, Inc., adjusted for certain nonrecurring
items that we do not believe directly reflect our core operations.
Adjusted net income per share, diluted, is calculated by dividing
adjusted net income by the total shares of Class A common stock
outstanding plus any dilutive warrants, options and restricted
stock as calculated in accordance with GAAP and assuming the full
exchange of all outstanding Paired Securities as of the beginning
of each period presented. Adjusted net income and adjusted net
income per diluted share, are supplemental measures of operating
performance that do not represent, and should not be considered,
alternatives to net income and earnings per share, as calculated in
accordance with GAAP. We believe adjusted net income and adjusted
net income per diluted share, supplement GAAP measures and enable
us to more effectively evaluate our performance period-over-period.
A reconciliation of net income (loss), the most directly comparable
GAAP measure, to adjusted net income and the computation of
adjusted net income per diluted share, are set forth below:
|
|
|
|
|
|
|
|
|
|
|
|
|
(in thousands, except
per share amounts)
|
|
Three Months Ended September
30,
|
|
|
Nine Months Ended September
30,
|
|
|
|
2023
|
|
|
2022
|
|
|
2023
|
|
|
2022
|
|
Net income
(loss)
|
|
$
|
(36,135)
|
|
|
$
|
1,957
|
|
|
$
|
(102,841)
|
|
|
$
|
(21,013)
|
|
Income tax (benefit)
expense, as reported
|
|
|
18
|
|
|
|
(631)
|
|
|
|
162
|
|
|
|
(6,617)
|
|
Change in fair value –
warrant liabilities
|
|
|
—
|
|
|
|
53
|
|
|
|
—
|
|
|
|
(4,221)
|
|
Loss on extinguishment
of debt
|
|
|
3,114
|
|
|
|
—
|
|
|
|
4,331
|
|
|
|
—
|
|
Loss on impairment of
goodwill
|
|
|
6,879
|
|
|
|
—
|
|
|
|
6,879
|
|
|
|
—
|
|
Board special committee
fees
|
|
|
—
|
|
|
|
—
|
|
|
|
14,160
|
|
|
|
—
|
|
Acquisition
expenses
|
|
|
—
|
|
|
|
3,389
|
|
|
|
65
|
|
|
|
3,389
|
|
Gain on effective
settlement in acquisition
|
|
|
—
|
|
|
|
(1,421)
|
|
|
|
—
|
|
|
|
(1,421)
|
|
Adjusted net income
(loss) before income taxes
|
|
|
(26,124)
|
|
|
|
3,347
|
|
|
|
(77,244)
|
|
|
|
(29,883)
|
|
Adjusted income tax
benefit (expense)(1)
|
|
|
6,766
|
|
|
|
(840)
|
|
|
|
20,006
|
|
|
|
7,082
|
|
Adjusted net income
(loss)
|
|
$
|
(19,358)
|
|
|
$
|
2,507
|
|
|
$
|
(57,238)
|
|
|
$
|
(22,801)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted net income
(loss) per share, diluted
|
|
$
|
(0.18)
|
|
|
$
|
0.03
|
|
|
$
|
(0.55)
|
|
|
$
|
(0.29)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted
weighted-average shares outstanding,
diluted(2)
|
|
|
105,744
|
|
|
|
86,115
|
|
|
|
103,380
|
|
|
|
78,992
|
|
|
|
|
|
(in thousands, except
per share amounts)
|
|
Three Months Ended June 30,
2023
|
|
Net income
(loss)
|
|
$
|
(40,654)
|
|
Income tax (benefit)
expense, as reported
|
|
|
72
|
|
Board special committee
fees
|
|
|
8,298
|
|
Adjusted net income
(loss) before income taxes
|
|
|
(32,284)
|
|
Adjusted income tax
benefit (expense)(1)
|
|
|
8,362
|
|
Adjusted net income
(loss)
|
|
$
|
(23,922)
|
|
|
|
|
|
|
Adjusted net income
(loss) per share, diluted
|
|
$
|
(0.23)
|
|
|
|
|
|
|
Adjusted
weighted-average shares outstanding,
diluted(2)
|
|
|
105,507
|
|
|
|
|
|
|
|
|
|
(1)
|
Represents the
estimated effective tax rate of 25.9% for the three and nine months
ended September 30, 2023 and for the three months ended June 30,
2023 , and 25.1% and 23.7% for the three and nine months ended
September 30, 2022, applied to adjusted net income before income
taxes. The estimated effective tax rates are what the Company would
be subject to and consist of the combined federal statutory tax
rate and the Company's blended state tax rates assuming no
valuation allowance .
|
|
|
(2)
|
Assumes options and
restricted stock units calculated in accordance with GAAP and the
full exchange of all outstanding Paired Securities for shares of
Class A common stock as of the beginning of the period.
|
A reconciliation of net income (loss) per share, diluted, to
adjusted net income per diluted share is set forth below for the
three and six months ended June 30,
2021 and 2020:
|
|
For the Three Months Ended
|
|
|
|
September 30, 2023
|
|
|
September 30, 2022
|
|
|
|
Net Income
|
|
|
Weighted
Average
Shares,
Diluted
|
|
|
Net Income
per
Share, Diluted
|
|
|
Net Income
|
|
|
Weighted
Average
Shares,
Diluted
|
|
|
Net Income
per
Share, Diluted
|
|
Net income (loss)
attributable to Purple Innovation Inc.(1)
|
|
$
|
(36,004)
|
|
|
|
105,326
|
|
|
$
|
(0.34)
|
|
|
$
|
1,956
|
|
|
|
86,115
|
|
|
$
|
0.02
|
|
Assumed exchange of shares(2)
|
|
|
(131)
|
|
|
|
418
|
|
|
|
|
|
|
|
1
|
|
|
|
—
|
|
|
|
|
|
Net
income (loss)
|
|
|
(36,135)
|
|
|
|
|
|
|
|
|
|
|
|
1,957
|
|
|
|
|
|
|
|
|
|
Adjustments to
arrive at adjusted income (loss) before
taxes(3)
|
|
|
10,011
|
|
|
|
|
|
|
|
|
|
|
|
1,390
|
|
|
|
|
|
|
|
|
|
Adjusted income (loss) before taxes
|
|
|
(26,124)
|
|
|
|
|
|
|
|
|
|
|
|
3,347
|
|
|
|
|
|
|
|
|
|
Adjusted income tax benefit(4)
|
|
|
6,766
|
|
|
|
|
|
|
|
|
|
|
|
(840)
|
|
|
|
|
|
|
|
|
|
Adjusted
net income (loss)
|
|
$
|
(19,358)
|
|
|
|
105,744
|
|
|
$
|
(0.18)
|
|
|
$
|
2,507
|
|
|
|
86,115
|
|
|
$
|
0.03
|
|
|
|
|
|
|
|
For the Three Months Ended
June 30, 2023
|
|
|
|
|
Net Income
|
|
|
Weighted
Average
Shares,
Diluted
|
|
|
Net Income
per
Share, Diluted
|
|
|
Net income (loss)
attributable to Purple Innovation Inc.(1)
|
|
$
|
(40,487)
|
|
|
|
105,079
|
|
|
$
|
(0.39)
|
|
|
Assumed exchange of shares(2)
|
|
|
(167)
|
|
|
|
428
|
|
|
|
|
|
|
Net
income (loss)
|
|
|
(40,654)
|
|
|
|
|
|
|
|
|
|
|
Adjustments to
arrive at adjusted income (loss) before
taxes(3)
|
|
|
8,370
|
|
|
|
|
|
|
|
|
|
|
Adjusted income (loss) before taxes
|
|
|
(32,284)
|
|
|
|
|
|
|
|
|
|
|
Adjusted income tax benefit(4)
|
|
|
8,362
|
|
|
|
|
|
|
|
|
|
|
Adjusted net income
(loss)
|
|
$
|
(23,922)
|
|
|
|
105,507
|
|
|
$
|
(0.23)
|
|
|
|
|
(1)
|
Represents net income
attributable to Purple Innovation, Inc. and the associated weighted
average diluted shares, of Class A common stock
outstanding.
|
|
|
(2)
|
Assumes the full
exchange of all outstanding Paired Securities for shares of Class A
common stock as of the beginning of the period and added in if not
already included in the weighted average diluted shares. Also
assumes the addition of net income attributable to noncontrolling
interests corresponding with the assumed exchange of the Paired
Securities for shares of Class A common stock.
|
|
|
(3)
|
Represents the total
impact of all adjustments identified in the adjusted net income
table above to arrive at adjusted income before income taxes. Also
assumes the dilutive warrants, options and restricted stock as
calculated in accordance with GAAP.
|
|
|
(4)
|
Represents the
estimated effective tax rate of 25.9% and 25.1% for the three
months ended September 30, 2023, and June 30, 2023 and 25.1% for
the three months ended September 30, 2022, applied to adjusted net
income before income taxes. The estimated effective tax rates are
what the Company would be subject to and consist of the combined
federal statutory tax rate and the Company's blended state tax
rates assuming no valuation allowance.
|
|
|
For the Nine Months Ended
|
|
|
|
September 30, 2023
|
|
|
September 30, 2022
|
|
|
|
Net Income
|
|
|
Weighted
Average
Shares,
Diluted
|
|
|
Net Income
per
Share, Diluted
|
|
|
Net Income
|
|
|
Weighted
Average
Shares,
Diluted
|
|
|
Net Income
per
Share, Diluted
|
|
Net income (loss)
attributable to Purple Innovation Inc.(1)
|
|
$
|
(102,424)
|
|
|
|
102,962
|
|
|
$
|
(0.99)
|
|
|
$
|
(20,809)
|
|
|
|
78,992
|
|
|
$
|
(0.27)
|
|
Assumed exchange of shares(2)
|
|
|
(417)
|
|
|
|
418
|
|
|
|
|
|
|
|
(204)
|
|
|
|
—
|
|
|
|
|
|
Net
income (loss)
|
|
|
(102,841)
|
|
|
|
|
|
|
|
|
|
|
|
(21,013)
|
|
|
|
|
|
|
|
|
|
Adjustments to
arrive at adjusted income before taxes(3)
|
|
|
25,597
|
|
|
|
|
|
|
|
|
|
|
|
(8,870)
|
|
|
|
|
|
|
|
|
|
Adjusted income before taxes
|
|
|
(77,244)
|
|
|
|
|
|
|
|
|
|
|
|
(29,883)
|
|
|
|
|
|
|
|
|
|
Adjusted income tax benefit
(expense)(4)
|
|
|
20,006
|
|
|
|
|
|
|
|
|
|
|
|
7,082
|
|
|
|
|
|
|
|
|
|
Adjusted net
income
|
|
$
|
(57,238)
|
|
|
|
103,380
|
|
|
$
|
(0.55)
|
|
|
$
|
(22,801)
|
|
|
|
78,992
|
|
|
$
|
(0.29)
|
|
|
|
(1)
|
Represents net income
attributable to Purple Innovation, Inc. and the associated weighted
average diluted shares, of Class A common stock
outstanding.
|
|
|
(2)
|
Assumes the full
exchange of all outstanding Paired Securities for shares of Class A
common stock as of the beginning of the period and added in if not
already included in the weighted average diluted shares. Also
assumes the addition of net income attributable to noncontrolling
interests corresponding with the assumed exchange of the Paired
Securities for shares of Class A common stock.
|
|
|
(3)
|
Represents the total
impact of all adjustments identified in the adjusted net income
table above to arrive at adjusted income before income taxes. Also
assumes the dilutive warrants, options and restricted stock as
calculated in accordance with GAAP.
|
|
|
(4)
|
Represents the
estimated effective tax rate of 25.9% and 23.7% for the nine months
ended September 30, 2023 and 2022, respectively, applied to
adjusted net income before income taxes. The estimated effective
tax rates are what the Company would be subject to and consist of
the combined federal statutory tax rate and the Company's blended
state tax rates assuming no valuation allowance.
|
View original content to download
multimedia:https://www.prnewswire.com/news-releases/purple-innovation-reports-third-quarter-2023-results-301983986.html
SOURCE Purple Innovation, Inc.